Fluciclovine is a potential imaging biomarker of glutamine utilisation in breast cancer
主要な著者: | Teoh, EJ, Bridges, EM, Morotti, M, Zois, CE, Lord, SR, Gleeson, FV, Harris, AL |
---|---|
フォーマット: | Conference item |
言語: | English |
出版事項: |
Springer
2017
|
類似資料
-
Fluciclovine (F-18) is a marker for high-affinity glutamine transporter ASCT2-mediated amino acid transport in breast cancer
著者:: Teoh, E, 等
出版事項: (2017) -
Characterising ¹⁸F-fluciclovine uptake in breast cancer through the use of dynamic PET/CT imaging
著者:: Scott, NP, 等
出版事項: (2021) -
Cancer imaging with fluciclovine (18F)
著者:: Teoh, E
出版事項: (2018) -
Increased expression of glutamine transporter SNAT2/SLC38A2 promotes glutamine dependence and oxidative stress resistance, and is associated with worse prognosis in triple-negative breast cancer
著者:: Morotti, M, 等
出版事項: (2020) -
Incidental Accumulation of Fluciclovine in Neuroendocrine Tumour in a Patient with Oncological Duplicity
著者:: Zuzana Balážová, 等
出版事項: (2020-04-01)